abstract |
The present invention relates to the use of NK3R antagonists for the treatment of pathological excess body fat in a patient and/or the prevention of increased body fat in a patient. The present invention also relates to a cosmetic method of stimulating excess body fat reduction, comprising administering an NK-3 receptor antagonist. |